On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.

Beilstein Journal of Organic Chemistry
Eirinaios I VrettosAndreas G Tzakos

Abstract

Cancer is the second leading cause of death affecting nearly one in two people, and the appearance of new cases is projected to rise by >70% by 2030. To effectively combat the menace of cancer, a variety of strategies have been exploited. Among them, the development of peptide-drug conjugates (PDCs) is considered as an inextricable part of this armamentarium and is continuously explored as a viable approach to target malignant tumors. The general architecture of PDCs consists of three building blocks: the tumor-homing peptide, the cytotoxic agent and the biodegradable connecting linker. The aim of the current review is to provide a spherical perspective on the basic principles governing PDCs, as also the methodology to construct them. We aim to offer basic and integral knowledge on the rational design towards the construction of PDCs through analyzing each building block, as also to highlight the overall progress of this rapidly growing field. Therefore, we focus on several intriguing examples from the recent literature, including important PDCs that have progressed to phase III clinical trials. Last, we address possible difficulties that may emerge during the synthesis of PDCs, as also report ways to overcome them.

References

May 1, 1990·Endocrine Reviews·M A Carson-JuricaB W O'Malley
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R Z CaiA V Schally
Jan 1, 1995·Annual Review of Cell and Developmental Biology·M A SchwartzM H Ginsberg
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·A NagyJ Horvath
Oct 1, 1996·Immunology and Cell Biology·V ApostolopoulosG A Pietersz
Apr 1, 1996·Journal of Ethnopharmacology·M E Wall, M C Wani
Dec 10, 1997·Journal of the National Cancer Institute·M MiyazakiP Armatis
Jul 17, 1999·European Journal of Endocrinology·A V Schally, A Nagy
May 10, 2000·The Journal of Biological Chemistry·E F PlowJ W Smith
Feb 24, 2001·Annals of the New York Academy of Sciences·L F LiuS P Sim
Mar 6, 2003·Bioorganic & Medicinal Chemistry Letters·Joseph A FuselierDavid H Coy
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·S S DharapT Minko
May 22, 2004·Annals of the New York Academy of Sciences·Hicham LahlouChristiane Susini
Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Sep 8, 2004·Trends in Endocrinology and Metabolism : TEM·Andrew V Schally, Attila Nagy
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·William M Pardridge
Jun 2, 2005·Nature Reviews. Cancer·Samir D UndeviaMark J Ratain
Jun 16, 2005·Animal Reproduction Science·A M Padula
Jul 19, 2005·Current Opinion in Chemical Biology·Selena Fung, Victor J Hruby
Aug 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·S S DharapT Minko
Dec 2, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zonghai LiJianren Gu
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Jun 17, 2006·Breast Cancer Research : BCR·Vasso ApostolopoulosStamatis Vassilaros
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hui XiaoGeorge A Orr
Oct 5, 2006·Anti-cancer Agents in Medicinal Chemistry·Weibo Cai, Xiaoyuan Chen
Mar 3, 2007·Immunology·Choon K TangVasso Apostolopoulos
Mar 6, 2008·Journal of Cellular and Molecular Medicine·Michael Vibo Grandal, Inger Helene Madshus
Apr 9, 2008·Acta Tropica·Grant Lewison, Divya Srivastava
Feb 3, 2009·Experimental and Molecular Pathology·Rajesh Singh, James W Lillard
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Jun 26, 2009·BMC Neurology·William A Banks

❮ Previous
Next ❯

Citations

May 6, 2019·International Journal of Molecular Sciences·Roopa DharmattiYoshihiro Ito
May 21, 2019·Expert Opinion on Drug Delivery·Behzad JafariYadollah Omidi
Oct 15, 2019·Angewandte Chemie·Anaïs F M NoisierRanganath Gopalakrishnan
Aug 23, 2019·Current Drug Delivery·Pritish Kumar PandaSanjay K Jain
Sep 29, 2019·International Journal of Molecular Sciences·Ivan RanđelovićJózsef Tóvári
Apr 3, 2020·Organic & Biomolecular Chemistry·Faisal Hayat, Marie E Migaud
Aug 1, 2020·Frontiers in Chemistry·Paul HoppenzAnnette G Beck-Sickinger
Jul 11, 2019·IUBMB Life·Susan SarhadiAmirhossein Sahebkar
Jun 18, 2020·Frontiers in Bioengineering and Biotechnology·Seema GuptaPradeep Kumar
Mar 10, 2020·Chemical Biology & Drug Design·Krishnamoorthy RajavenkateshSathiah Thennarasu
Oct 31, 2020·Nucleic Acids Research·Balázs BaloghIstván M Mándity
Dec 22, 2020·Chemical Society Reviews·Bethany M CooperDavid R Spring
Jan 21, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Xue ZhouXinli Liu
Oct 31, 2020·Current Opinion in Biotechnology·Mathias Schmelcher, Martin J Loessner
Jan 21, 2021·Cancers·Martina Cirillo, Daria Giacomini
Feb 11, 2021·International Journal of Molecular Sciences·Adina BorbélyGitta Schlosser
Feb 6, 2020·Bioorganic Chemistry·Kinga PioreckaWlodzimierz A Stanczyk
Feb 23, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sabrina DallavalleRoberta Fruttero
Mar 5, 2020·Seminars in Nephrology·David C Yang, Ching-Hsien Chen
Mar 17, 2020·Pharmacology & Therapeutics·Marcos V PeriniAshwini L Chand
May 28, 2019·Cancer Letters·Ying LiuJianxun Wang
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Félix GayraudInes Neundorf
Jun 15, 2021·Dalton Transactions : an International Journal of Inorganic Chemistry·Anastasia KougioumtziAndreas G Tzakos
Jun 26, 2021·Infectious Diseases and Therapy·Bilal AslamZulqarnain Baloch
Jul 3, 2021·Cells·Nuria Tubío-SantamaríaElke Krüger
Jan 1, 2021·Journal of Medicinal Chemistry·Mona AlasKamaljit Kaur
Feb 9, 2019·Journal of Medicinal Chemistry·Brian H WhiteMark T Bilodeau
Nov 12, 2021·Journal of Drug Targeting·Mishal Pokharel, Kihan Park

❮ Previous
Next ❯

Methods Mentioned

BETA
phage display
deamination
xenografts

Clinical Trials Mentioned

NCT02828774

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Hematology & Oncology
Michael Firer, Gary Gellerman
Journal of Peptide Science : an Official Publication of the European Peptide Society
David Böhme, Annette G Beck-Sickinger
© 2022 Meta ULC. All rights reserved